Fig. 6From: Comprehensive tumor molecular profile analysis in clinical practiceSimulation of patients' biomarker-defined categorization based on their most clinically significant variant when the analysis is performed using either the 161 or the 50 or the 24 gene panels. The following categories were used: 1A/1B: patients carrying Tier 1 alterations, 2C.1: patients with 2C.1 alterations, 2C.2/2D Patients with 2C.2 or 2D alterationsBack to article page